NCT00351832View on ClinicalTrials.gov

A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

June 30, 2006

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Vildagliptin

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY